Battelle Memorial Institute

Battelle is the largest independent research and development organization globally, based in Columbus, Ohio. Established in 1929, it operates as a nonprofit private foundation focused on advancing scientific discovery and innovation. Battelle brings together experts in various fields to foster collaboration between people, science, and technology, aiming to accelerate advancements that benefit society. The organization is governed by a board of directors, ensuring that its resources are directed towards impactful research and development initiatives.

Lewis Von Thaer

President and CEO

6 past transactions

COSI

Grant in 2023
Center of Science and Industry in Columbus, OH

AmplifyBio

Funding Round in 2021
AmplifyBio is a biotechnology company that develops next-generation cell and gene therapies. The company's mission is to create pathways for novel treatment advances, cutting-edge technologies, and new research frontiers to advance medical breakthroughs, treatments, and cures for disease. AmplifyBio was founded in 2021 and is headquartered in West Jefferson, OH.

Allonnia

Series A in 2021
Allonnia LLC offers waste remediation services. The company engages in the development of enzymes, proteins, and microbes that degrade or metabolize contaminants and enables them to recover and upcycle valuable materials from waste and existing biological treatment processes. Allonnia LLC was incorporated in 2019 and is based in Boston, Massachusetts.

Allonnia

Series A in 2020
Allonnia LLC offers waste remediation services. The company engages in the development of enzymes, proteins, and microbes that degrade or metabolize contaminants and enables them to recover and upcycle valuable materials from waste and existing biological treatment processes. Allonnia LLC was incorporated in 2019 and is based in Boston, Massachusetts.

Ventaira Pharmaceuticals

Acquisition in 2007
Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company dedicated to the development of innovative inhalation products. The company employs its proprietary electrohydrodynamic aerosolization and formulation technologies to create new inhaled drugs. Among its key products are fentanyl, aimed at treating breakthrough pain, and salmeterol, used for asthma management. Ventaira Pharmaceuticals focuses on advancing its unique technologies to enhance drug delivery and improve treatment options for patients.

Ventaira Pharmaceuticals

Series B in 2003
Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company dedicated to the development of innovative inhalation products. The company employs its proprietary electrohydrodynamic aerosolization and formulation technologies to create new inhaled drugs. Among its key products are fentanyl, aimed at treating breakthrough pain, and salmeterol, used for asthma management. Ventaira Pharmaceuticals focuses on advancing its unique technologies to enhance drug delivery and improve treatment options for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.